©The Author(s) 2026.
World J Gastroenterol. Feb 14, 2026; 32(6): 114600
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.114600
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.114600
Table 2 League table showing pairwise comparisons of included interventions
| Interventions | |||||
| Body mass index reduction [MD (95%CI)] | |||||
| OAGBantiflux | RYGB | SG | SGantiflux | ||
| OAGB | 2.60 (0.16-5.04) | 0.10 (-1.47 to 1.68) | -0.83 (-2.73 to 1.07) | -1.96 (-4.61 to 0.70) | |
| OAGBantiflux | - | -2.50 (-5.40 to 0.40) | -3.43 (-6.52 to -0.34) | -4.56 (-8.16 to -0.95) | |
| RYGB | - | - | -0.94 (-2.28 to 0.41) | -2.06 (-4.35 to 0.23) | |
| SG | - | - | - | -1.12 (-2.98 to 0.73) | |
| Percent excess weight loss [MD (95%CI)] | |||||
| RYGB | SG | SGantiflux | |||
| OAGB | -3.70 (-7.24 to -0.16) | -7.71 (-12.58 to -2.83) | -9.71 (-19.36 to -0.05) | ||
| RYGB | - | -4.01 (-8.47 to 0.45) | -6.01 (-15.46 to 3.45) | ||
| SG | - | - | -2.00 (-10.34 to 6.34) | ||
| GERD remission [RD (95%CI)] | |||||
| OAGBantiflux | RYGB | SG | SGantiflux | ||
| OAGB | -0.41 (-3.71 to 2.89) | 2.95 (-1.21 to 7.10) | 1.61 (-3.10 to 6.31) | 0.85 (-4.79 to 6.49) | |
| OAGBantiflux | - | 3.35 (-1.95 to 8.66) | 2.01 (-3.73 to 7.76) | 1.26 (-5.27 to 7.79) | |
| RYGB | - | - | -1.34 (-3.55 to 0.87) | -2.09 (-5.90 to 1.72) | |
| SG | - | - | - | -0.75 (-3.86 to 2.35) | |
| GERD onset [RR (95%CI)] | |||||
| OAGBantiflux | RYGB | SG | SGantiflux | ||
| OAGB | -1.43 (-2.71 to -0.15) | -1.15 (-1.94 to -0.36) | 0.32 (-0.69 to 1.33) | 0.42 (-1.09 to 1.92) | |
| OAGBantiflux | - | 0.28 (-1.23 to 1.78) | 1.75 (0.12-3.38) | 1.84 (-0.13 to 3.82) | |
| RYGB | - | - | 1.47 (0.69-2.25) | 1.57 (0.21-2.92) | |
| SG | - | - | - | 0.09 (-1.02 to 1.20) | |
| Change in proton pump inhibitor usage [RR (95%CI)] | |||||
| RYGB | SG | SGantiflux | |||
| OAGB | -0.03 (-0.22 to 0.16) | 0.14 (-0.11 to 0.38) | 0.01 (-0.35 to 0.38) | ||
| RYGB | - | 0.16 (0.00-0.32) | 0.04 (-0.27 to 0.35) | ||
| SG | - | - | -0.12 (-0.39 to 0.15) | ||
| Change in esophagitis [RR (95%CI)] | |||||
| RYGB | SG | SGantiflux | |||
| OAGB | 0.40 (0.34-0.47) | 0.45 (0.39-0.50) | 0.23 (0.17-0.29) | ||
| RYGB | - | 0.04 (0.01-0.08) | -0.17 (-0.21 to -0.13) | ||
| SG | - | - | -0.21 (-0.23 to -0.20) | ||
| Complication [RD (95%CI)] | |||||
| OAGBantiflux | RYGB | SG | SGantiflux | ||
| OAGB | -1.28 (-3.11 to 0.56) | -0.24 (-1.04 to 0.57) | -0.25 (-1.12 to 0.62) | 1.15 (-0.58 to 2.88) | |
| OAGBantiflux | - | 1.04 (-0.96 to 3.04) | 1.03 (-1.00 to 3.06) | 2.43 (-0.10 to 4.95) | |
| RYGB | - | - | -0.01 (-0.64 to 0.61) | 1.38 (-0.24 to 3.00) | |
| SG | - | - | - | 1.40 (-0.10 to 2.89) | |
- Citation: Xing Y, Yan WM, Bai RX. Effects of bariatric surgery on obesity associated gastroesophageal reflux disease: Insights from a systematic review and network meta-analysis. World J Gastroenterol 2026; 32(6): 114600
- URL: https://www.wjgnet.com/1007-9327/full/v32/i6/114600.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i6.114600